West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West's new Integrated Solutions Program will provide customers with a comprehensive approach to drug containment and delivery system development. Available in defined and customized packages, the new offering will combine West's suite of drug packaging and delivery products with West's proven expert testing and support services, to meet the unique needs of the drug product and its delivery system at any stage of development, across all injectable formats.
"Our customers are under increasing pressure to move new therapies to market quickly while maintaining cost efficiencies – all while enduring increased regulatory scrutiny," said
While the Integrated Solutions Program is new, West has well-established quality and regulatory expertise, which will be featured in the following poster and panel presentations at PDA:
- October 8—3:45 to
5:15 p.m. —B2: Building Clarity in Addressing Regulatory Challenges for Combination Products, Moderated byFran DeGrazio , Vice President, Scientific Affairs & Technical Services, West - October 8—3:
15 to 3:45 p.m. —What's New with the Regulations? A Well-Rounded Approach to Regulatory Performance Testing for Combination Products, Daniel L. Bantz, Technology Manager, West - October 9—7:
15 to 7:40 a.m. —Impact of Excipients on Functionality,Liang Fang , Principal Research Scientist, West (co-presented withGalen Shi , PhD, Advisor,Eli Lilly and Company ) October 8 and October 9—10:00 to 10:45 a.m. and 3:00 to 3:45 p.m.—Gx RTF® syringes and NovaPure™ plunger stoppers,Katie Espenshade , SME Specialist, CZ, PDS, Combination Products, West (co-presented withMaximilian Vogl , Global Head of Product Management Gx® Solutions,Gerresheimer )
At CPhI Worldwide, in recognition of West's enduring commitment to both quality and corporate sustainability, West will be highlighted as a finalist in the CPhI Awards for Excellence in Pharma for the categories of Supply Chain, Logistics and Distribution and Corporate Social Responsibility. The CPhI Awards for Excellence in Pharma celebrate companies that turn inspiration into innovation to drive the pharmaceutical industry forward.
In addition to showcasing its full portfolio of drug containment and delivery technologies, West will also introduce
For more information on West products and services, including Daikyo Crystal Zenith® containment & delivery systems, its Westar® Select quality enhancement offering, NovaPure™ components, SelfDose™ patient-controlled injector and SmartDose™ drug delivery platform, visit Booth #506 at PDA Universe of Prefilled Syringes and Injection Devices,
Forward-Looking Statements
Certain forward-looking statements are included in this press release. They use such words as "will," "new," "proven," "allow," "reduce," "accelerate," "minimize," "improve" and other similar terminology. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. There is no certainty that actual results will be achieved in-line with current expectations or that the services will achieve any particular result. These forward-looking statements involve a number of risks and uncertainties. The following are some of the factors that could cause our actual results to differ materially from those expressed in or underlying our forward-looking statements: customer decisions to move forward with our new service offerings and the ability to meet development milestones with key customers. These important factors are not all inclusive. For a description of certain additional factors that could cause the Company's future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended
About West
West and the diamond logo, Westar®, NovaPure™ and SelfDose™ are registered trademarks or trademarks of
SmartDose™ is a trademark of West Pharma.
Daikyo D Sigma®, RUV®, RSV®, and Crystal Zenith® are registered trademarks of Daikyo Seiko, Ltd. Daikyo Crystal Zenith® technology is licensed from
RTF® is a registered trademark of
Gx® is a registered trademark of
Media Contact:
Senior Director, Global Communications
+1-610-594-3054
Michele.Pelkowski@westpharma.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-highlights-integrated-solutions-offering-and-related-technical-and-regulatory-expertise-at-upcoming-industry-events-300725369.html
SOURCE